GRANTING BIOWAIVER FOR IMMEDIATE RELEASE SOLID ORAL DOSAGE FORMS OF AMOXICILLIN: RESULTS OF A LITERATURE REVIEW
- At: 2015 FIP Congress in Düsseldorf (Germany)
- Type: Poster
- By: THAMBAVITA, Dhanusha (Faculty of Medicine, University of Colombo, Pharmacology, Colombo-08, Sri Lanka)
- Co-author(s): Dhanusha Thambavita
Biowaiver(BW) monographs pertaining to waiving of in vivo bioequivalence(BE) are available for drugs belonging to Biopharmaceutics Classification System(BCS) class 1 and III. World Health Organization(WHO) classifies amoxicillin to BCS class 1 but no BW monograph is available as yet. We reviewed literature relevant to a BW monograph for.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.